Who owns Lexicon Pharmaceuticals?
- Ticker: LXRX
- CUSIP Number: 528872302
Tip: Access positions for across all investors
Analyze quarterly positions in Lexicon Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Lexicon Pharmaceuticals stock
Who bought or sold Lexicon Pharmaceuticals this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Artal Group | 118M | $282M | 0% | Mar 2024 |
|
FMR | 14M | $33M | 84% | Mar 2024 |
|
BlackRock | 7.7M | $19M | 16% | Mar 2024 |
|
Vanguard Group | 6.4M | $15M | 7% | Mar 2024 |
|
OrbiMed Advisors | 3.5M | $8.5M | 100% | Mar 2024 |
|
Geode Capital Management | 2.4M | $5.7M | 12% | Mar 2024 |
|
NEA Management Company | 2.4M | $5.7M | 0% | Mar 2024 |
|
Susquehanna International | 2.3M | $5.5M | 347% | Mar 2024 |
|
Gail Mannix | 1.7M | $4.2M | 1% | Mar 2024 |
|
BVF | 1.7M | $4.0M | -93% | Mar 2024 |
|
Ameriprise Financial | 1.4M | $3.4M | 17% | Mar 2024 |
|
Cubist Systematic Strategies | 1.4M | $3.4M | 100% | Mar 2024 |
|
Schonfeld Strategic Advisors | 960k | $5.3M | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 881k | $2.1M | 2% | Mar 2024 |
|
Northern Trust | 867k | $2.1M | -25% | Mar 2024 |
|
Point72 Asset Management | 584k | $1.4M | 100% | Mar 2024 |
|
Millennium Management | 534k | $1.3M | -67% | Mar 2024 |
|
Nuveen Asset Management | 524k | $1.3M | 28% | Mar 2024 |
|
Marshall Wace | 499k | $1.2M | 100% | Mar 2024 |
|
Citadel Advisors | 370k | $889k | -59% | Mar 2024 |
|
ExodusPoint Capital Management | 319k | $766k | 100% | Mar 2024 |
|
GSA Capital Partners | 293k | $704k | -62% | Mar 2024 |
|
Virtus ETF Advisers | 293k | $703k | 17% | Mar 2024 |
|
Bank of New York Mellon | 292k | $701k | -14% | Mar 2024 |
|
Jane Street | 282k | $676k | 3% | Mar 2024 |
|
Alliancebernstein | 245k | $375k | 0% | Dec 2023 |
|
Morgan Stanley | 244k | $586k | 2% | Mar 2024 |
|
Two Sigma Investments | 189k | $455k | -7% | Mar 2024 |
|
UBS Group | 167k | $401k | -2% | Mar 2024 |
|
Goldman Sachs Group | 156k | $375k | -34% | Mar 2024 |
|
Rhumbline Advisers | 135k | $324k | 3% | Mar 2024 |
|
T. Rowe Price Associates | 105k | $253k | 5% | Mar 2024 |
|
Commonwealth Equity Services | 95k | $228k | 178% | Mar 2024 |
|
Compagnie Lombard, Odier SCA | 94k | $226k | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 90k | $216k | -97% | Mar 2024 |
|
LPL Financial | 90k | $216k | 233% | Mar 2024 |
|
Natixis Asset Management Advisors | 86k | $207k | 100% | Mar 2024 |
|
Bank of America Corporation | 86k | $206k | -59% | Mar 2024 |
|
Barclays | 65k | $155k | -49% | Mar 2024 |
|
Pathstone Holdings | 63k | $151k | 82% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 59k | $143k | 83% | Mar 2024 |
|
Stifel Financial | 52k | $125k | 32% | Mar 2024 |
|
Lazard Freres Gestion S.A.S. | 50k | $119k | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 50k | $120k | 100% | Mar 2024 |
|
Russell Investments | 49k | $118k | 0% | Mar 2024 |
|
China Universal Asset Management | 47k | $113k | 66% | Mar 2024 |
|
American International | 46k | $71k | 0% | Dec 2023 |
|
Virtu Financial | 44k | $105k | 100% | Mar 2024 |
|
KWB Wealth | 41k | $98k | 0% | Mar 2024 |
|
Bank Of Montreal | 40k | $88k | 100% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 39k | $93k | -4% | Mar 2024 |
|
University of Texas Investment Management Company | 36k | $86k | 0% | Mar 2024 |
|
Balyasny Asset Management | 34k | $83k | 100% | Mar 2024 |
|
ProShare Advisors | 34k | $81k | 20% | Mar 2024 |
|
New York State Common Retirement Fund | 34k | $81k | 0% | Mar 2024 |
|
Prosperity Financial Group | 32k | $76k | 0% | Mar 2024 |
|
Victory Capital Management | 31k | $75k | -3% | Mar 2024 |
|
Wells Fargo & Company | 31k | $74k | 16% | Mar 2024 |
|
BBR Partners | 30k | $72k | 100% | Mar 2024 |
|
Florida State Board of Administration | 29k | $71k | 22% | Mar 2024 |
|
Ing Investment Management | 29k | $70k | -22% | Mar 2024 |
|
Tiaa Trust, National Association | 27k | $65k | 0% | Mar 2024 |
|
HPM Partners | 23k | $54k | 100% | Mar 2024 |
|
Wolverine Trading | 21k | $50k | -65% | Mar 2024 |
|
Principal Securities | 20k | $48k | -7% | Mar 2024 |
|
SG Americas Securities | 19k | $46k | -56% | Mar 2024 |
|
Tower Research Capital | 18k | $43k | 7% | Mar 2024 |
|
Citigroup | 18k | $42k | -92% | Mar 2024 |
|
Hrt Financial | 17k | $40k | 100% | Mar 2024 |
|
JustInvest | 16k | $37k | 2% | Mar 2024 |
|
Branch Banking & Trust Company | 13k | $31k | 4% | Mar 2024 |
|
North Star Asset Management | 13k | $30k | 100% | Mar 2024 |
|
Coyle Financial Counsel | 13k | $30k | 100% | Mar 2024 |
|
Pinnacle Wealth Management Advisory | 12k | $30k | 0% | Mar 2024 |
|
Chemistry Wealth Management | 12k | $29k | 0% | Mar 2024 |
|
Berger Financial Group | 11k | $26k | 0% | Mar 2024 |
|
Raymond James & Associates | 11k | $26k | 0% | Mar 2024 |
|
Captrust Financial Advisors | 11k | $26k | -76% | Mar 2024 |
|
Cetera Investment Advisers | 11k | $26k | 100% | Mar 2024 |
|
Principal Financial Group | 11k | $25k | 0% | Mar 2024 |
|
LifeSteps Financial | 10k | $24k | 0% | Mar 2024 |
|
Estabrook Capital Management | 10k | $24k | 0% | Mar 2024 |
|
California State Teachers Retirement System | 9.3k | $22k | -92% | Mar 2024 |
|
Summit Investment Advisors | 8.9k | $21k | 65% | Mar 2024 |
|
Legal & General Group | 8.2k | $20k | -26% | Mar 2024 |
|
Nordwand Advisors | 4.0k | $9.6k | 100% | Mar 2024 |
|
Amalgamated Bank | 2.4k | $6.0k | -76% | Mar 2024 |
|
National Bank Of Canada /fi/ | 2.2k | $3.5k | 0% | Dec 2023 |
|
Royal Bank of Canada | 2.2k | $0 | -93% | Mar 2024 |
|
Quintet Private Bank | 1.9k | $3.0k | 0% | Dec 2023 |
|
Advisor Group Holdings | 1.4k | $3.4k | 3% | Mar 2024 |
|
Quadrant Capital | 1.4k | $3.3k | 0% | Mar 2024 |
|
Us Bancorp | 1.2k | $2.9k | 100% | Mar 2024 |
|
Signature | 1.2k | $2.8k | -27% | Mar 2024 |
|
Global Retirement Partners | 1.0k | $2.4k | 0% | Mar 2024 |
|
Northwestern Mutual Wealth Management Company | 500.00 | $1.2k | 0% | Mar 2024 |
|
Daiwa Securities Group | 434.00 | $999.979400 | 0% | Mar 2024 |
|
Efficient Wealth Management | 407.00 | $999.999000 | 0% | Mar 2024 |
|
Syntax Research | 142.00 | $340.998800 | 0% | Mar 2024 |
|
Brian McDonald | 122.00 | $292.995200 | 100% | Mar 2024 |
|
Pnc Financial Services | 111.00 | $266.000400 | 0% | Mar 2024 |
|
Covestor | 66.00 | $0 | 0% | Mar 2024 |
|
Coppell Advisory Solutions | 52.00 | $80.002000 | -54% | Dec 2023 |
|
NISA Investment Advisors | 49.00 | $118.001800 | 100% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 21.00 | $50.001000 | 100% | Mar 2024 |
|
Atlantic Trust | 10.00 | $23.000000 | 100% | Mar 2024 |
|
CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Farther Finance Advisors | 2.00 | $5.000000 | 0% | Mar 2024 |
|
Who sold out of Lexicon Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Parkman Healthcare Partners | Sep 2023 | 1.1M | $1.2M |
Wellington Management Company | Sep 2023 | 379k | $413k |
D. E. Shaw & Co | Dec 2023 | 359k | $550k |
Connor, Clark & Lunn Investment Management | Dec 2023 | 283k | $432k |
Qube Research & Technologies | Sep 2023 | 277k | $302k |
ClariVest Asset Management | Sep 2023 | 192k | $210k |
Deerfield Management Company | Dec 2023 | 103k | $158k |
Verition Fund Management | Sep 2023 | 92k | $100k |
Amundi | Dec 2023 | 55k | $81k |
Simplex Trading | Dec 2023 | 54k | $82k |
Tudor Investment Corporation | Dec 2023 | 47k | $72k |
MetLife Investment Advisors | Sep 2023 | 43k | $47k |
Two Sigma Securities | Dec 2023 | 38k | $59k |
Bayesian Capital Management | Dec 2023 | 32k | $49k |
Rpo | Dec 2023 | 32k | $49k |
Beacon Pointe Advisors | Sep 2023 | 23k | $25k |
Cantor Fitzgerald, L. P. | Dec 2023 | 17k | $25k |
Federated Investors | Sep 2023 | 17k | $18k |
Assetmark | Dec 2023 | 10k | $15k |
Metropolitan Life Insurance Company | Sep 2023 | 4.6k | $5.0k |
Advisory Services Network | Dec 2023 | 242.00 | $369.824400 |
Headlands Technologies | Dec 2023 | 204.00 | $311.997600 |
JNBA Financial Advisors | Dec 2023 | 13.00 | $20.000500 |